You are here:

quetiapine fumerate (Seroquel XL)


Following an abbreviated submission

quetiapine prolonged-release tablet (Seroquel XL®) is accepted for use within NHS Scotland for the treatment of schizophrenia and manic episodes associated with bipolar disorder.

It is suitable for patients in whom quetiapine is an appropriate choice of antipsychotic. For equivalent doses it has similar or lower costs compared to immediate-release quetiapine.

Drug Details

Drug Name: quetiapine fumerate (Seroquel XL)
SMC Drug ID: 433/07
Manufacturer: AstraZeneca UK Ltd
Indication: Schizophrenia in adults (18 years and over)
BNF Category:
Sub Category: 4.2 Drugs used in psychoses and related disorders
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 10 November 2008